ACKERMANS & VAN HAAREN NV |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 158.2 EUR | -0.57% |
|
-0.25% | -0.38% |
| Feb. 29 | ACKERMANS & VAN HAAREN : Ackermans signs off a fast year |  |
| Feb. 29 | ACKERMANS & VAN HAAREN : AvH released solid 2023 figures | |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- With a P/E ratio at 11.45 for the current year and 9.87 for next year, earnings multiples are highly attractive compared with competitors.
- The company's share price in relation to its net book value makes it look relatively cheap.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- For the past twelve months, EPS forecast has been revised upwards.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- Historically, the company has been releasing figures that are above expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Construction & Engineering
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -0.38% | 5.52B | C | ||
| -0.22% | 58.01B | C+ | ||
| +12.72% | 35.61B | B+ | ||
| +11.43% | 30.81B | B | ||
| +0.61% | 25.96B | A- | ||
| +27.29% | 22.73B | B- | ||
| +12.87% | 19.03B | A | ||
| +19.83% | 17.69B | B+ | ||
| +52.55% | 15.47B | B | ||
| +14.59% | 15.17B | B |
Investor Rating
Trading Rating
ESG Refinitiv
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Environment
Emissions
Innovation
Use of resources
Governance
CSR Strategy
Management
Shareholders
Controversy
Controversy
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- ACKB Stock
- Ratings Ackermans & van Haaren NV
